These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3199684)

  • 1. Long-term experience of spironolactone in essential hypertension.
    Jeunemaitre X; Kreft-Jais C; Chatellier G; Julien J; Degoulet P; Plouin PF; Ménard J; Corvol P
    Kidney Int Suppl; 1988 Oct; 26():S14-7. PubMed ID: 3199684
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of low-dose spironolactone on resistant hypertension.
    Engbaek M; Hjerrild M; Hallas J; Jacobsen IA
    J Am Soc Hypertens; 2010; 4(6):290-4. PubMed ID: 21130975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerance of spironolactone in essential hypertension.
    Jeunemaitre X; Chatellier G; Kreft-Jais C; Charru A; DeVries C; Plouin PF; Corvol P; Menard J
    Am J Cardiol; 1987 Oct; 60(10):820-5. PubMed ID: 3661395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
    Kreeft JH; Larochelle P; Ogilvie RI
    Can Med Assoc J; 1983 Jan; 128(1):31-4. PubMed ID: 6336600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long term therapy over nine years with Spironolacton in hydropic cardiac insufficiency].
    Ehrlich U; Klepzig H
    Med Klin; 1976 Sep; 71(38):1546-54. PubMed ID: 135920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spironolactone in essential hypertension. Controlled study on the dose-response relationship].
    Orabona ML; Maiorano G; Loiacono N
    Minerva Cardioangiol; 1975 Dec; 23(12):866-70. PubMed ID: 1232582
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combination therapy with spironolactone and polythiazide in hypertension].
    Lund-Johansen P
    Nord Med; 1971; 86(49):1471-4. PubMed ID: 5137025
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol.
    Lavenius B; Hansson L
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):291-5. PubMed ID: 7049966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spironolactone and hydrochlorothiazide in essential hypertension. Blood pressure response and plasma renin activity.
    Adlin EV; Marks AD; Channick BJ
    Arch Intern Med; 1972 Dec; 130(6):855-8. PubMed ID: 5082465
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of spironolactone on blood pressure in subjects with resistant hypertension.
    Chapman N; Dobson J; Wilson S; Dahlöf B; Sever PS; Wedel H; Poulter NR;
    Hypertension; 2007 Apr; 49(4):839-45. PubMed ID: 17309946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complications of verospirone therapy].
    Bokarev IN; Baranova NV
    Klin Med (Mosk); 1987 Sep; 65(9):104-8. PubMed ID: 3695298
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of essential hypertension with spironolactone with reference to the plasma renin activity].
    Esch I; Placheta P
    Wien Klin Wochenschr; 1973 Jun; 85(23):413-7. PubMed ID: 4575841
    [No Abstract]   [Full Text] [Related]  

  • 13. Antialdosterones: incidence and prevention of sexual side effects.
    de Gasparo M; Whitebread SE; Preiswerk G; Jeunemaître X; Corvol P; Ménard J
    J Steroid Biochem; 1989 Jan; 32(1B):223-7. PubMed ID: 2913412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Good blood pressure control on antihypertensives, not only response to spironolactone, predicts improved outcome after adrenalectomy for aldosteronoma.
    Zarnegar R; Lee J; Brunaud L; Lindsay S; Kebebew E; Clark OH; Duh QY
    Surgery; 2007 Dec; 142(6):921-9; discussion 921-9. PubMed ID: 18063077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of essential arterial hypertension with a thiazide-spironolactone-reserpine derivative combination].
    Klepping C; Villand J
    J Med Lyon; 1971 Sep; 52(213):1139-41. PubMed ID: 4400152
    [No Abstract]   [Full Text] [Related]  

  • 16. [Relation between the pressure response to spironolactone and or propranolol and the arterial hypertension pattern].
    Chiarini C; Degli Esposti E; Zuccalà A; Bellanova B; Zucchelli P
    Minerva Nefrol; 1974; 21(4):334-9. PubMed ID: 4467054
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of spironolactone and hydrochlorothiazide on blood pressure levels and blood potassium. Controlled studies on hypertensive patients].
    Ambrosioni E; Costa FV; Magnani B
    G Clin Med; 1974 Nov; 55(11):782-97. PubMed ID: 4469883
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypotensive effect of spironolactone in patients with essential hypertension and aldosterone regulation disorders].
    Wambach G; Helber A; Bönner G; Hummerich W; Meurer KA; Kaufmann W
    Med Welt; 1980 Aug; 31(31-32):1135-7. PubMed ID: 7421547
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of benign essential hypertension with an association of spironolactone and thiabutazide: an open multicenter study in general practice (author's transl)].
    Rhomberg F; Leya A
    Schweiz Rundsch Med Prax; 1981 Dec; 70(50):2269-78. PubMed ID: 7031639
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of the anti-hypertensive effect of spironolactone: trial of combined therapy with spironolactone and alpha-methyldopa].
    Cagli V
    Clin Ter; 1976 Feb; 76(3):253-60. PubMed ID: 963964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.